Why the study?
Does the choice of beta-blocker (atenolol, labetalol, metoprolol, or pindolol) affect antihypertensive efficacy and side effect profile in patients with mild to moderate hypertension?
Does the choice of beta-blocker (atenolol, labetalol, metoprolol, or pindolol) affect antihypertensive efficacy and side effect profile in patients with mild to moderate hypertension?
Answers are grounded in this paper and cite their sources.
While atenolol, labetalol, metoprolol, and pindolol can achieve similar antihypertensive effects at varying doses, they differ in their effects on pulse rate and side effect profiles.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
McNeil et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: